Obstructive jaundice treatment during the COVID-19 pandemic: retrospective cohort study at a single tertiary care center in Serbia.

Borislav ToskovicBatrić VukčevićDarko ZdravkovicBogdan CrnokrakIgor NadjAna SekulicDavor MrdaSlobodan TodorovicRanko LazovicVladimir Milosavljevic

Published in: The Journal of international medical research (2023)

COVID-19 infection is a risk factor in treating obstructive jaundice. This study illustrates the potential influence of COVID-19 on mortality after obstructive jaundice treatment. COVID-19 pneumonia may be a significant risk factor for mortality in patients treated for obstructive jaundice.

Keyphrases

coronavirus disease
sars cov
tertiary care
risk factors
type diabetes
coronary artery disease
risk assessment
intensive care unit
acute respiratory distress syndrome